Brought to you by 
AqueSys brings in $7.5mm through its Series C round so far
11 Jun 2021
Executive Summary
AqueSys Inc. (implant to stop blindness due to glaucoma) has raised $7.5mm through its Series C venture round. According to the company's Form D, it may bring in another $27.5mm before closing.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
AqueSys brings in $7.5mm through its Series C round so far
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice